Refractory Angina Treatment Market is driven by Innovative TherapeuticsNew Section
Refractory angina, characterized by chronic chest pain unresponsive to standard medical and revascularization therapies, affects a significant subset of ischemic heart disease patients. The market offers a spectrum of advanced interventions—including novel pharmacological agents (such as ivabradine and ranolazine), gene therapy vectors, cell-based regenerative treatments, enhanced...
0 Commenti 0 condivisioni 825 Views 0 Anteprima
Sponsorizzato

Trade with the best

aking Exness the first name that comes to mind when people think about brokers or trading. We’re putting our traders first, not only with trading conditions, but also with the overall...